1)      Yoshii I, Whiteside LA, Anouchi YS. The effect of patellar button placement and femoral component design on patellar tracking in total knee arthroplasty. Clinical orthopaedics and related research. 1992 Feb 1;275:211-9.

2)      Yoshii I, Whiteside LA, White SE, Milliano MT. Influence of prosthetic joint line position on knee kinematics and patellar position. The Journal of arthroplasty.1991 Jun 30;6(2):169-77.

3)      Yoshii I, Whiteside LA, Milliano MT, White SE. The effect of central stem and stem length on micromovement of the tibial tray. The Journal of arthroplasty. 1992 Dec 31;7:433-8.

4)      Yoshii I, Whiteside LA. The Effect of Flexibility and Central Stem of the Cementless Total Knee Tibial Tray on Initial Fixation. Biomechanics in Orthopedics 1992 (pp. 237-252). Springer Japan.

5)      Yoshii I, Satake Y, Kitaoka K, Komatsu M, and Hashimoto K. Relationship between dementia degree and gait ability after surgery of proximal femoral fracture. J Orthop Science 2016 21(4); 481-486. 2016.

6)      Yoshii I, Chijiwa T, Sawada N. The influence of pain score measured by a visual analog scale (PS-VAS) on the Health Assessment Questionnaire Disability Index (HAQ-DI) and 28-joint disease activity index with C-reactive protein (DAS28-CRP) in rheumatoid arthritis patients. Int J Rheum Dis 2018 Nov. 21(11):1955-61.

7)      Yoshii I, Kitaoka K, Hashimoto K. Clinical characteristics of osteoporotic second fracture: From the data of Clinical Pathway with Regional Alliance in rural region in Japan. J Orthop Sci 2019 Feb 13. pii: S0949-3658(19)30008-9. Doi: 10.1016/j.jos.2018.12.029. [Epub ahead of print]

8)      Yoshii I. Serum cystatin C level can be an early predictor in community-living people?: A clinical question to the conclusion. Mod Rheumatol 2020;30(1):211-2. Doi: 10.1080/14397595.2019.1383710.

9)      Yoshii I, Chijiwa T, Sawada N. Screening osteoporotic femoral neck without measuring bone mineral density with the use of tartrate resistant acid phosphatase-5b and serum-creatinine-to-cystatin C ratio in Japanese postmenopausal women. J Orthop Sci 2019 July 20. pii: S0949-2658(19)30204-0. Doi: 10.1016/j.jos.2019.07.002 [Epub ahead of print]

10)  Yoshii I, Chijiwa T, Sawada N. Validity of adopting a Health Assessment Questionnaire Disability Index less than 0.5 as a target in elderly rheumatoid arthritis patients. Clin Rheumatol. 2019;38(12):3351-60. Doi: 10.1007/s10067-019-04692-1.

11)  Yoshii I, Kondo M. Clinical characteristics of frailty in Japanese rheumatoid arthritis patients. J Frailty Aging. 2019. Vol 8. [Epub ahead of print]

12)  Yoshii I, Chijiwa T, Sawada N. Efficacy and safety of targeted strategy for treating rheumatoid arthritis patients aged 75 years or older. Tohoku J Exp Med. 2020;250 (1):13-23.

13)  Yoshii I, Akita K. Cortical thickness relative to the transverse diameter to third metacarpal bone reflects bone mineral density in patients with rheumatoid arthritis. Bone. 2020 May 3;137:115405. Doi: 10.1016/j.bone.2020.115405. [Epub ahead of print]

14)  Yoshii I, Chijiwa T, Sawada N. Rheumatoid arthritis in tight disease control is no longer risk of bone mineral density loss. Osteoporosis and Sarcopenia. 2020 June 4;pii: S2405525520300376. Doi: 10.1016/j.afos.2020.04.002

15)  Yoshii I, Chijiwa T. Effectiveness of duloxetine for remnant pain relief in patients with rheumatoid arthritis despite remission. Drugs Ther Perspect. 2020. May 25. pii: S40267-020-00739-5. Doi: 10.1007/s40267-020-00739-5.

16)  Yoshii I. Attaining CDAI remission is the first gateway to attain Boolean remission. Semin Arthritis Rheum. 2020;50(4):624-6.

17)  Yoshii I, Nishiyama S. The impact of shrunken pore syndrome in patient with rheumatic diseases on bone mineral metabolism. Scand J Clin Lab Invest. 2021;81(1):72-81.